Litcius/Paper detail

MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice

Lu Wang, Lei Wu, Shui-juan Zhang, Yao Li

2020Bioorganic & Medicinal Chemistry48 citationsDOIOpen Access PDF

Topics & Concepts

InflammationARDSBronchoalveolar lavageLungLipopolysaccharideInflammasomeCOPDMedicinePharmacologyImmunologyPyrin domainReceptorChemistryInternal medicineInflammasome and immune disordersImmune Response and InflammationInflammation biomarkers and pathways
MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice | Litcius